SGLT2 inhibitors reduce atrial fibrillation progression in Diabetes, finds study Medha Baranwal3 Sept 2020 11:00 AM ISTChina: The use of SGLT2 inhibitors in type 2 diabetes (T2D) patients may help in atrial fibrillation (AF)/atrial flutter (AFL) reduction,...
SGLT2 inhibitors with metformin do not increase fracture risk in diabetics: Study Medha Baranwal21 Aug 2020 11:15 AM ISTChina: Combination therapy with SGLT2 inhibitors and metformin in patients with type 2 diabetes (T2D) does not increase fracture risk versus metformin...
Prescribe SGLT2 inhibitors or GLP1 receptor agonists to reduce CV risk in diabetes: Expert Consensus Medha Baranwal6 Aug 2020 4:25 PM ISTThe American College of Cardiology has released the 2020 expert consensus decision pathway (ECDP) on novel therapies for cardiovascular risk reduction...
Ertugliflozin safe bet to lower blood sugar, BP and weight in elderly diabetics: Study Medha Baranwal6 Aug 2020 12:00 PM ISTUSA: The use of ertugliflozin can improve blood sugar, blood pressure, and body weight in both younger and older patients with type 2 diabetes (T2D),...
SGLT2 inhibitor Bexagliflozin reduces blood sugar, high BP and weight in diabetics Medha Baranwal19 Jun 2020 5:30 PM ISTDelhi: The investigational drug Bexagliflozin was found to be well-tolerated in high-risk diabetes patients in a phase 3 study. According to the...
SGLT2 inhibitors may protect diabetics against serious kidney problems Hina Zahid30 April 2020 12:30 PM ISTUse of sodium glucose cotransporter 2 (SGLT2) inhibitors to treat type 2 diabetes may help to lower the risk of serious kidney problems, finds a study...
Stop SGLT2 inhibitors just before surgery- FDA advises label changes Dr. Kamal Kant Kohli19 March 2020 11:30 AM ISTThe Food and Drug Administration has approved safety changes in labeling of all sodium-glucose transporter 2 (SGLT2) inhibitors .The new changes in...
SGLT2 inhibitors tied to ketoacidosis in latent autoimmune diabetes Hina Zahid20 Jan 2020 11:36 AM ISTSodium-glucose co-transporter-2 (SGLT2) inhibitors can cause ketoacidosis in patients with latent autoimmune diabetes (LADA), a report on three cases...
SGLT2 inhibitors can lead to serious genital infection: USFDA warning Ruby Khatun Khatun31 Aug 2018 9:00 AM ISTThe SGLT2 inhibitors approved by the FDA include Johnson and Johnson's Invokana, Eli Lilly & Co's Jardiance, as well as those from Bristol-Myers...
